Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan;36(1):e11-e13.
doi: 10.1111/jdv.17665. Epub 2021 Sep 27.

Reply to "Psoriasis exacerbation after COVID-19 vaccination: report of 14 cases from a single centre" by Sotiriou E et al

M Megna  1 , L Potestio  1 , L Gallo  1 , G Caiazzo  1 , A Ruggiero  1 , G Fabbrocini  1
Affiliations
Comment

Reply to "Psoriasis exacerbation after COVID-19 vaccination: report of 14 cases from a single centre" by Sotiriou E et al

M Megna et al. J Eur Acad Dermatol Venereol. 2022 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

Comment on

References

    1. Sotiriou E, Tsentemeidou A, Bakirtzi K et al. Psoriasis exacerbation after Covid‐19 vaccination: report of 14 cases from a single center. J Eur Acad Dermatol Venereol 2021. 10.1111/jdv.17582 - DOI - PMC - PubMed
    1. Damiani G, Allocco F, Malagoli P. COVID‐19 vaccination and patients with psoriasis under biologics: real‐life evidence on safety and effectiveness from Italian vaccinated healthcare workers. Clin Exp Dermatol 2021; 46: 1106–1108. - PMC - PubMed
    1. Skroza N, Bernardini N, Tolino E et al. Safety and impact of Anti‐COVID‐19 vaccines in psoriatic patients treated with biologics: a real life experience. J Clin Med 2021; 10: 3355. - PMC - PubMed
    1. Governo italiano, Report Vaccini Anti COVID‐19. URL https://www.governo.it/it/cscovid19/report‐vaccini/ (last accessed 13 Aug 2021).
    1. Megna M, Ruggiero A, Marasca C et al. Biologics for psoriasis patients in the COVID‐19 era: more evidence, less fears. J Dermatolog Treat 2020; 31: 328–329. 10.1080/09546634.2020.1757605 - DOI - PubMed

Substances